To investigate the potential clinical relevance of BTC in ovarian cancer, we queried 489 ovarian cancers from The Cancer Genome Atlas (TCGA [30]) for up-regulation of BTC mRNA above the median. This evidence concerns the gene BTC and ovarian cancer.